From the god of sun to immunodeficiency: identification of a new rare disease affecting hematopoiesis and immunity

From the god of sun to immunodeficiency: identification of a new rare disease affecting hematopoiesis and immunity

A disturbed Helios-dependent epigenetic regulation mechanism causes T and B cell defects in an inborn immune disease. (Vienna, 26.11.2021) Together with international collaborators, scientists at the St. Anna Children’s Cancer Research Institute discover a new inborn error of hematopoiesis and immunity, caused by an inherited genetic defect of the transcription factor…

New FWF-grant approved: Decoding the epigenome and its regulation in neuroblastoma

New FWF-grant approved: Decoding the epigenome and its regulation in neuroblastoma

(Vienna, 23.11.2021) CONGRATS to Irfete Fetahu, PhD, postdoc at St. Anna CCRI on receiving a Stand-Alone Grant from the Austrian Science fund FWF. Together with her PI Sabine-Taschner-Mandl from the Tumor Biology group and colleagues, Irfete has the ambitious goal to decode the epigenome and its regulation in neuroblastoma, a…

Sabine Taschner-Mandl is elected to the executive board of Europe’s neuroblastoma network SIOPEN

Sabine Taschner-Mandl is elected to the executive board of Europe’s neuroblastoma network SIOPEN

(Vienna, 20.10.2021) Developing new therapies for childhood nerve tumors and identifying more molecular markers for better diagnosis – this is what Sabine Taschner-Mandl strives for in her new role as Executive Committee Board Member of the European Neuroblastoma Research Group SIOPEN. Sabine Taschner-Mandl, PhD, head of the Tumor Biology Research…

EU Commissioner visits St. Anna: "Europe’s Beating Cancer Plan puts the spotlight on childhood cancer"

EU Commissioner visits St. Anna: "Europe’s Beating Cancer Plan puts the spotlight on childhood cancer"

(Vienna, 08.09.2021) Childhood cancer is different from cancer in adults. Thus, it needs research specifically tailored to pediatric tumors, which requires dedicated funding. The need for medicines suitable for children, as well as improvements in long-term follow-up care for cancer survivors have been discussed with EU Health Commissioner Stella Kyriakides,…

Kaan Boztug awarded the "Işil Berat Barlan Award for Primary Immunodeficiency Diseases"

Kaan Boztug awarded the "Işil Berat Barlan Award for Primary Immunodeficiency Diseases"

(Vienna, 03.09.2021) Congratulations! Assoc.-Prof. Kaan Boztug, MD, Scientific Director of the St. Anna Children's Cancer Research Institute and Director of the Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, has been awarded the Işil Berat Barlan Award for his outstanding research in the field of primary immunodeficiencies, which will be…